Submissions from 2026
Topical roflumilast 0.3% cream for mild hidradenitis suppurativa: A prospective case series, Nagasai C. Adusumilli, Nikkia Zarabian, Mina Farah, Emily C. Murphy, and Adam J. Friedman
Prevalence, incidence, and risk factors for dermatologic conditions in people with HIV in the modern antiretroviral era: A cohort study in Washington, DC, Yagiz Matthew Akiska, Morgan Byrne, Mana Nasseri, Adeline Koay, Michael A. Horberg, Anne Monroe, Adam Friedman, and Natella Rakhmanina
Utilization and predictors of use of immunomodulators for atopic dermatitis: A cohort study, Priyanka Anand, Arash Mostaghimi, Robert Glynn, Yinzhu Jin, Joseph F. Merola, Jonathan I. Silverberg, David M. Rosmarin, Robert Sidbury, Joan Landon, and Maria C. Schneeweiss
Barriers to optimal psoriasis care from patient and provider perspectives: A multinational survey, A P. Bewley, H Crawford, I Ingvarsson, Y Zhong, D Proudman, L Korrapati, D Nellesen, C Daamen, A López-Ferrer, and N T. Issa
Impact of IL-23 inhibition versus methotrexate on select major fracture risk and progression to joint arthroplasty in psoriatic patients, Dion Birhiray, Ben Gratz, Stephen Rossettie, Leonardo Tjahjono, and Addisu Mesfin
The Epidemiology of Atopic Dermatitis among Adults and Adolescents with Alopecia Areata in the United States, Christopher G. Bunick, April W. Armstrong, Ayman Grada, Ahmed M. Soliman, Chao Li, Claire C. Bristow, Imran A. Khan, Dawid Lipiszko, Jonathan I. Silverberg, Naiem T. Issa, and Arash Mostaghimi
Classification of High Curl Pattern Hair: A Systematic Review and Clinical Perspective, Valerie Callender, Cheryl Burgess, Valerie M. Harvey, Candrice Heath, Hope Mitchell, Heather Woolery-Lloyd, Anneke Andriessen, and Amy McMichael
High Curl Pattern Hair and Scalp Care Considerations to Mitigate Seborrheic Dermatitis, Valerie Callender, Cheryl Burgess, Valerie M. Harvey, Candrice Heath, Hope Mitchell, Heather Woolery-Lloyd, Anneke Andriessen, and Amy McMichael
Model-informed drug development to support nemolizumab clinical development in adults and adolescents with moderate to severe atopic dermatitis, Floris Fauchet, Anna Largajolli, Petra M. Jauslin, Emilie Schindler, Mourad Hamimed, Wannee Kantasiripitak, Antonio Gonçalves, Eline Van Maanen, Khaled Benkali, Tomohisa Saito, Jonathan I. Silverberg, Andreas Wollenberg, Michael Graeber, Liliana Ulianov, Christophe Piketty, Luca Loprete, Vincent Duval, and Nathalie Wagner
Ethical implications of advertising in medical journals, Lauren Fleshner, Gustavo Freitas, Timothy Klufas, Albert E. Zhou, and Jane M. Grant-Kels
Long-term efficacy of abrocitinib in patients with moderate-to-severe atopic dermatitis to 2 years, Melinda J. Gooderham, Jonathan I. Silverberg, Marjolein De Bruin-Weller, Leon Kircik, Diamant Thaçi, Zuotao Zhao, Fernando Valenzuela, Toshifumi Nomura, Andrew Selfridge, Dorothy Fan, Daniela E. Myers, Pinaki Biswas, Saleem A. Farooqui, Melissa Watkins, and Herwig Koppensteiner
Retrospective Assessment of Social Rejection Related to Atopic Dermatitis During Childhood and Adolescence: The Scars of Life-Eczema Study, Bruno Halioua, Jerry Tan, Chaoying Gu, Thomas Luger, Julien Seneschal, Roni Dodiuk-Gad, Roberto Takaoka, Flavia Pretti Aslanian, Cita Rosita Prakoeswa, Ann' Laure Demessant-Flavigny, Caroline Le Floc'h, Nabil Kerrouche, Stéphanie Merhand, Wendy Smith Begolka, África Luca de Tena Smith, Shulamit Burstein, Delphine Kerob, Charles Taieb, Charbel Skayem, Abraham Getachew Kelbore, Laurent Misery, Therdpong Tempark, Alexander Stratigos, Martin Steinhoff, and Jonathan I. Silverberg
Liver Transplantation for Diffuse Infantile Hepatic Hemangioma and Acute Liver Failure: A Case Report, Elana P. Kleinman, Nada A. Yazigi, Carolina Rumbo, Roaa A. Aljuaid, Udeme D. Ekong, Khalid M. Khan, Bhaskar V. Kallakury, Anna Yasmine Kirkorian, Colleen H. Cotton, Radhika Srivastava, Kelly M. Weaver, Julia Clayton, Michelle Eaton, Piyush Gupta, Brian M. Nguyen, Gabriel J. Hauser, Cal S. Matsumoto, and Gabriel E. Gondolesi
Inflammatory and fibrotic biomarkers in patients with atopic dermatitis treated with cendakimab, Jie Li, Coryandar Gilvary, Lu Gao, Evan S. Dellon, Christina M. Charriez, Claudia H. de Oliveira, Misti J. Linaberry, Sarah Harris, and Jonathan I. Silverberg
The Long-Term Impact of Childhood and Adolescent Atopic Dermatitis on Physical and Psychosocial Well-Being: Scars of Life project, Thomas Luger, Roberto Takaoka, Jerry Tan, Chaoying Gu, Flavia Pretti Aslanian, Roni Dodiuk-Gad, Cita Rosita Prakoeswa, Bruno Halioua, Charbel Skayem, Ann'Laure Demessant Flavigny, Caroline Le Floc'h, Nabil Kerrouche, Stéphanie Merhand, Wendy Smith Begolka, África Luca Smith, Shulamit Burstein, Delphine Kerob, Charles Taieb, Therdpong Tempark, Abraham Getachew Kelbore, Julien Seneschal, Martin Steinhoff, Alexander Stratigos, Laurent Misery, and Jonathan I. Silverberg
Hand Eczema Is Independently Associated with Significant Quality of Life Impact in Patients with Atopic Dermatitis, Grishma Patel, Jacob P. Thyssen, and Jonathan I. Silverberg
The development of a global health dermatologic surgery training program in Durban, South Africa, Vishal A. Patel, Myra A. Zaheer, Matthew Liu, Muhammad Peer, Anisa Mosam, Ncoza Cordelia Dlova, and Chrysalyne Delling Schmults
A Clinical Commentary on Facial Botulinum Toxin A Use Among Transgender Women: Unique Considerations Among Gender-Diverse Populations, Vincent Pecora, Rayva Khanna, and Pooja Sodha
Occupational Contact Dermatitis in North American Healthcare Workers: Trends & Triggers (2005-2022), Margo J. Reeder, Mayra Betancourt Ponce, Vijayram Patel, Erin M. Warshaw, Amber R. Atwater, Joel G. DeKoven, Brandon L. Adler, Donald V. Belsito, Jonathan I. Silverberg, James S. Taylor, Cory A. Dunnick, Peggy Wu, Jonathan Zippin, Vincent A. DeLeo, Christen M. Mowad, Marie-Claude Houle, Jiade Yu, Melanie D. Pratt, and Nina Botto
Risk of Acne in Patients With Atopic Dermatitis Starting a JAK Inhibitor vs Th2 Cytokine Inhibitor, Maria C. Schneeweiss, Richard Wyss, Priyanka Anand, Yinzhu Jin, Arash Mostaghimi, John Barbieri, Joseph F. Merola, Jonathan I. Silverberg, David M. Rosmarin, Robert J. Glynn, and Sebastian Schneeweiss
The National Psoriasis Foundation Primer on GLP-1 Receptor Agonists in Psoriasis: A Review, Samip Sheth, Joseph F. Merola, Brittany N. Weber, Ronald Prussick, Jensen Yeung, Clive Liu, Brad Glick, Soumya M. Reddy, Fran E. Cook-Bolden, Elizabeth Wallace, Michael Garshick, José O. Alemán, Guy S. Eakin, Jeffrey M. Cohen, and Andrew Blauvelt
Guidelines of care for the primary prevention of atopic dermatitis and awareness of comorbid conditions in pediatric atopic dermatitis, Robert Sidbury, Ali Alikhan, Lionel Bercovitch, David E. Cohen, Jennifer M. Darr, Aaron M. Drucker, Lawrence F. Eichenfield, Lindsy Frazer-Green, Amy S. Paller, Kathryn Schwarzenberger, Jonathan I. Silverberg, Anne Marie Singh, Peggy A. Wu, and Dawn M. Davis
Lebrikizumab Improves Clinical Manifestations, Symptoms, and Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis Previously Treated with Dupilumab: Results from the ADapt Study, Jonathan I. Silverberg, Lindsay Ackerman, Jerry Bagel, Linda Stein Gold, Andrew Blauvelt, David Rosmarin, Raj Chovatiya, Matthew Zirwas, Gil Yosipovitch, Jill Waibel, Jenny E. Murase, Ben Lockshin, Jamie Weisman, Amber Reck Atwater, Jennifer Proper, Maria Silk, Evangeline Pierce, Maria Lucia Piruzeli, Sonia Montmayeur, Christopher Schuster, Jinglin Zhong, Maria Jose Rueda, Sreekumar Pillai, and Eric Simpson
Lebrikizumab off-therapy remission sustained up to 38 weeks in atopic dermatitis, Jonathan I. Silverberg, Thomas Bieber, Kilian Eyerich, April W. Armstrong, Brian J. Nickoloff, Chitra R. Natalie, Gaia Gallo, Angela Okragly, Eric Wolf, Chenjia Xu, Brian A. Moser, Maria Jose Rueda, Hany Elmaraghy, Ozge Uluckan, and Johann E. Gudjonsson
Patch Test Reactions Associated with Food Sources: A Retrospective Analysis of the North American Contact Dermatitis Group Data (2001-2018), Jonathan I. Silverberg, Seung Hyun Cheong, Erin M. Warshaw, Joel G. DeKoven, Brandon L. Adler, Melanie D. Pratt, Donald V. Belsito, Amber R. Atwater, Marie-Claude Houle, Cory A. Dunnick, Jiade Yu, James S. Taylor, Margo J. Reeder, Vincent A. DeLeo, Christen Mowad, and Nina C. Botto
Expert Recommendations for the Diagnosis and Management of Chronic Hand Eczema in the United States, Jonathan I. Silverberg, David Cohen, Emma Guttman-Yassky, Lawrence F. Eichenfield, Eric L. Simpson, April Armstrong, JiaDe Yu, Linda Stein-Gold, Benjamin D. Ehst, Wendy Smith Begolka, Christopher G. Bunick, and Raj Chovatiya
Expert Recommendations for the Diagnosis and Management of Chronic Hand Eczema in the United States, Jonathan I. Silverberg, David Cohen, Emma Guttman-Yassky, Lawrence F. Eichenfield, Eric L. Simpson, April Armstrong, JiaDe Yu, Linda Stein-Gold, Benjamin D. Ehst, Wendy Smith Begolka, Christopher G. Bunick, and Raj Chovatiya
More than a symptom: itch as an independent clinical contributor in atopic dermatitis - a global-scale study on 15,223 patients, Jonathan I. Silverberg, Roni Dodiuk-Gad, Roberto Takaoka, Jerry Tan, Chaoying Gu, Thomas Luger, Bruno Halioua, Flavia Pretti Aslanian, Cita Rosita Prakoeswa, Ann'Laure Demessant Flavigny, Caroline Le Floc'h, Nabil Kerrouche, Stéphanie Merhand, Wendy Smith Begolka, África Luca Smith, Shulamit Burstein, Therdpong Tempark, Abraham Getachew, Delphine Kerob, Charles Taieb, Charbel Skayem, Alexander Stratigos, Martin Steinhoff, Julien Seneschal, and Laurent Misery
The 487-gene expression profile test guides systemic therapy selection to improve outcomes for patients with atopic dermatitis: Results from a prospective trial, Jonathan I. Silverberg, Lawrence F. Eichenfield, April W. Armstrong, Jerry Bagel, Ben Lockshin, Erin Boh, John Koo, Aaron S. Farberg, Matthew S. Goldberg, Ann P. Quick, and Mark G. Lebwohl
Atopic dermatitis beyond the skin: Characterizing skin pain in the "Scars of Life" study, Jonathan I. Silverberg, Roberto Takaoka, Jerry Tan, Thomas Luger, Chaoying Gu, Roni Dodiuk-Gad, Flavia Pretti Aslanian, Cita Rosita Sigit Prakoeswa, Bruno Halioua, Ann'Laure Demessant Flavigny, Caroline Le Floc'h, Nabil Kerrouche, Stéphanie Merhand, Wendy Smith Begolka, África Luca de Tena Smith, Shulamit Burstein, Delphine Kerob, Charles Taieb, Charbel Skayem, Therdpong Tempark, Abraham Getachew Kelbore, Julien Seneschal, Alexander Stratigos, Martin Steinhoff, and Laurent Misery
Bimekizumab for recalcitrant pyoderma gangrenosum, Christina Tolete, Adam Friedman, Joaquin Calderon, and Leonardo Tjahjono
Psychiatric safety of bimekizumab versus interleukin-23 inhibitors in psoriasis: A real-world TriNetX cohort study, Christina Tolete, Adam Friedman, Joaquin Calderon, and Leonardo Tjahjono
Upadacitinib for treatment of recalcitrant central centrifugal cicatricial alopecia, Christina Tolete, Adam Friedman, Joaquin Calderon, and Leonardo Tjahjono
Increased risk of hair loss with GLP-1 receptor agonists: A real-world multicenter TrinetX cohort study, Savanna I. Vidal, Yagiz Matthew Akiska, Mana Nasseri, Nikita Menta, Dillon Nussbaum, Colleen H. Cotton, Leslie Castelo-Soccio, and Adam Friedman
The Atopic Dermatitis Shared Decision-Making Tool: Implementing the AHEAD Approach in Clinical Practice, Andreas Wollenberg, Melinda Gooderham, Norito Katoh, Valeria Aoki, Andrew E. Pink, Yousef Binamer, and Jonathan I. Silverberg
Diagnosis, Workup, and Treatment of Idiopathic Granulomatous Mastitis, Isabel C. Yoon, Roxana Shirazi, Varshini Babu, Emily R. Nadelmann, Eric E. Morgan, Ari Brooks, and Misha Rosenbach
Targeting Mast Cells in Chronic Spontaneous Urticaria, Nikkia Zarabian, Mina Farah, Amanda Stines, and Adam Friedman
Submissions from 2025
Paving the Way to Healthcare Equity: A Comprehensive Review of Care Gaps and Emerging Initiatives in Dermatology, Andrew Alexis, Raj Chovatiya, Susan Taylor, Nada Elbuluk, Chesahna Kindred, Amber R. Atwater, Meena Hansen, Maria Jose Rueda, Tanja Bosshard Becker, Vivian Shi, and Seemal R. Desai
Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical Trial, Andrew Alexis, Amy McMichael, Jennifer Soung, Olivia Choi, Theodore Alkousakis, Javier Alonso-Llamazares, Mona Shahriari, Adrian O. Rodriguez, Tina Bhutani, Daphne Chan, Katelyn Rowland, Maxwell Sauder, H Chih-Ho Hong, Geeta Yadav, Jensen Yeung, Jenny Jeyarajah, Tony Ma, Long-Long Gao, Laura Park-Wyllie, Lawrence Green, Mark Lee, Neelam Vashi, Chesahna Kindred, Pearl Grimes, Susan C. Taylor, and Seemal R. Desai
Large Basal Cell Carcinoma Treated with Combination Topical Therapy, Kabir Al-Tariq, Rama Abdin, and Naiem T. Issa
Defining On-Treatment Remission in Plaque Psoriasis: A Consensus Statement From the National Psoriasis Foundation, April W. Armstrong, George C. Gondo, Joseph F. Merola, Alyssa M. Roberts, Lourdes M. Pérez-Chada, Deepak M. Balak, Guy S. Eakin, Charlotte Read, Stephanie T. Le, Yasmin Gutierrez, Tina Bhutani, Andrew Blauvelt, Kristina Callis Duffin, Steven Fakharzadeh, Steven R. Feldman, Joel M. Gelfand, Dafna D. Gladman, Brad Glick, Lawrence J. Green, George Han, Jason E. Hawkes, Samuel T. Hwang, Nicole Johnsen, Robert E. Kalb, Leon Kircik, Richard G. Langley, Mark G. Lebwohl, G Michael Lewitt, Emanual Maverakis, Ronald Prussick, Soumya M. Reddy, and Cheryl F. Rosen
Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis, Matthias Augustin, April Armstrong, Naiem T. Issa, Anne Sohrt Petersen, Rie von Eyben, Teodora Festini, and Tiago Torres
Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open-label extension study, Matthias Augustin, Marie Tauber, Robert Sidbury, Jonathan I. Silverberg, Kim A. Papp, Diamant Thaçi, Marjolein S. De Bruin-Weller, Adam Reich, Ketty Peris, Kirk Barber, Ryszard Galus, Andrzej Kaszuba, Matthew Zirwas, Walter K. Nahm, Gretel Trullenque, Laura Maintz, Sady Alpizar, Sang Wook Son, Vivian Laquer, Linda Stein Gold, Soo Yeon Cheong, Anna Ryzhkova, Agnes Drahos, Liliana Ulianov, and Christophe Piketty
Improving the quality of atopic dermatitis epidemiological research in the United States- A systematic review of disease definitions and related content in national surveys, Sarah L. Becker, Gina N. Bash, Wendy Smith Begolka, Tenesha Wallace-Hood, Junko Takeshita, Aaron M. Drucker, Jonathan Silverberg, Lawrence F. Eichenfield, Katrina Abuabara, Bryan Dosono, Andrew Hamilton, Robyn Okereke, and Eric Simpson
Skin Clearance, Duration of Treatment-free Interval, and Safety of Tapinarof Cream 1% Once Daily: Results from ADORING 3, a 48-week Phase 3 Open-label Extension Trial in Adults and Children Down to 2 Years of Age with Atopic Dermatitis, Robert Bissonnette, Linda Stein Gold, Leon Kircik, Eric L. Simpson, Lawrence F. Eichenfield, John Browning, Adelaide A. Hebert, Andrew F. Alexis, Weily Soong, Stephen C. Piscitelli, Anna M. Tallman, David S. Rubenstein, Philip M. Brown, and Jonathan I. Silverberg
Lebrikizumab is associated with improvements in patient-reported symptoms and quality-of-life measures across Eczema Area and Severity Index response categories: pooled results from phase-3 randomized ADvocate1 and ADvocate2 studies in patients with moderate-to-severe atopic dermatitis, Andrew Blauvelt, Leon Kircik, Todd Schlesinger, Evangeline Pierce, Russel Burge, Michael Behling, Amber Reck Atwater, Hany ElMaraghy, and April Armstrong
Clarifying Psoriasis Disease Severity: A Position Statement from the National Psoriasis Foundation Medical Board, Andrew Blauvelt, Ronald Prussick, Joseph F. Merola, Mona Shahriari, Jennifer Cather, Guy S. Eakin, Leah McCormick Howard, Mark G. Lebwohl, April W. Armstrong, and Kristina Callis Duffin
Two for One: Tuberculid and Leukocytoclastic Vasculitis in an Adolescent, Jordan K. Bui, Mairead Baker, and Kaiane Habeshian
Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 years, Christopher G. Bunick, Alan D. Irvine, Jonathan I. Silverberg, Emma Guttman-Yassky, Mona Shahriari, Xinghua Gao, Stephan Weidinger, Norito Katoh, Namita Vigna, Deanne M. Dilley, Elvira D'Andrea, Henrique D. Teixeira, Andrew M. Platt, and Gweneth F. Levy
Systemic Corticosteroid Use in Atopic Dermatitis: A Position Paper to Inform Safer Clinical Practice and Policy, Joshua Burshtein, Christopher G. Bunick, Ruth Ann Vleugels, April W. Armstrong, Alexandra K. Golant, Todd Schlesinger, Bruce E. Strober, Eingun James Song, Linda Stein Gold, and Mark Lebwohl
A Modified Tissue-Saving Technique with Silver Nitrate to Obliterate Tunnels for Hidradenitis Suppurativa, Hannah R. Chang, Emily Murphy, Duaa Abdel Hameid, Madeline Ngo, and Melissa M. Mauskar
The Importance of Comprehensive Patch Testing: A Call to Action from the American Contact Dermatitis Society, Jennifer K. Chen, Amber Reck Atwater, Donald V. Belsito, Alison Ehrlich, James S. Taylor, JiaDe Yu, Alexandra Flamm, and Bruce Brod
Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect Comparison, Raj Chovatiya, April Armstrong, Leon Kircik, Lluís Puig, Mark G. Kirchhof, Tiago Torres, Yousef Binamer, Gleison Duarte, Bülent Akmaz, Martin Dossenbach, Gaia Gallo, Chao Yang, Lucia Seminario-Vidal, Yuxin Ding, and Jonathan I. Silverberg
Exploring Two New, Validated Disease-Specific Outcome Measures to Assess Severity of Chronic Hand Eczema: Investigator Global Assessment of Chronic Hand Eczema (IGA-CHE) and Hand Eczema Symptom Diary (HESD)-A Podcast, Raj Chovatiya, Benjamin Ehst, and Jonathan Silverberg
Touch Avoidance and Emotional Impact in Adults with Chronic Hand Eczema: A Nationwide Cohort Study, Maria O. Christensen, Lea K. Nymand, Caroline Olesen, Silvia Mariel Ferrucci, Marie Louise Schuttelaar, Jonathan I. Silverberg, Claus Zachariae, Simon F. Thomsen, Jacob P. Thyssen, and Alexander Egeberg
Long-Term Safety of Abrocitinib in Moderate-to-Severe Atopic Dermatitis: Integrated Analysis by Age, Michael J. Cork, Mette Deleuran, Bob Geng, Jonathan I. Silverberg, Eric L. Simpson, Linda F. Stein Gold, Alan D. Irvine, William Romero, Hernan Valdez, Haiyun Fan, and Justine Alderfer
Targeted dual biologic therapy for erythroderma of unknown etiology guided by high-parameter peripheral blood immunophenotyping, Hannah L. Cornman, Martin P. Alphonse, Arbor Dykema, Alexander L. Kollhoff, Kevin K. Lee, Jaya Manjunath, Emily Z. Ma, Varsha Parthasarathy, Junwen Deng, Thomas Pritchard, Anusha Kambala, Melika Marani, Kayla A. Parr, Javid P. Mohammed, Madan M. Kwatra, Jay H. Bream, Won Jin Ho, and Shawn G. Kwatra
Focused update: Guidelines of care for the management of atopic dermatitis in adults, Dawn M. Davis, Lindsy Frazer-Green, Ali Alikhan, Lionel Bercovitch, David E. Cohen, Jennifer M. Darr, Aaron M. Drucker, Lawrence F. Eichenfield, Amy S. Paller, Kathryn Schwarzenberger, Jonathan I. Silverberg, Anne Marie Singh, Peggy A. Wu, and Robert Sidbury
Comparison Between Brazilian Propolis and Chinese Propolis: Results From the North American Contact Dermatitis Group 2019-2022, Joel G. DeKoven, Samuel J. DeKoven, Erin M. Warshaw, Amber Reck Atwater, Margo J. Reeder, James S. Taylor, Marie-Claude Houle, Donald V. Belsito, Melanie D. Pratt, Brandon L. Adler, Jonathan Silverberg, Cory A. Dunnick, Christen M. Mowad, Nina Botto, JiaDe Yu, Peggy A. Wu, Jonathan H. Zippin, and Anton C. de Groot
International insights into bullying in patients with atopic dermatitis: Global trends and key predictors, Roni Dodiuk-Gad, Roberto Takaoka, Laurent Misery, Jerry Tan, Chaoying Gu, Thomas Luger, Flavia Pretti Aslanian, Cita Rosita Prakoeswa, Ann'Laure Demessant Flavigny, Caroline Le Floc'hc, Nabil Kerrouche, Stéphanie Merhand, Wendy Smith Begolka, África Luca de Tena Smith, Shulamit Burstein, Delphine Kerob, Charles Taieb, Charbel Skayem, Bruno Halioua, Therdpong Tempark, Abraham Getachew Kelbore, Julien Seneschal, Alexander Stratigos, Martin Steinhoff, and Jonathan I. Silverberg
Use of Midodrine for Intraoperative Hemostasis in Cutaneous and Percutaneous Surgery, Joanna Dong, Naiem T. Issa, Michael Kaiser, Simonetta I. Gaumond, Michael Solis, Joel Gil, Robert S. Kirsner, Stephen C. Davis, and Joaquin J. Jimenez
Unmet Needs of Effective Advanced Systemic Therapies in Moderate-to-Severe Atopic Dermatitis Patients in the TARGET-DERM AD Registry, Dawn Z. Eichenfield, Keith D. Knapp, Ami Claxton, Breda Munoz, Julie M. Crawford, Sanjeev Balu, Yestle Kim, Shannon Schneider, Michael A. Haft, Jonathan I. Silverberg, Diamant Thaci, Lawrence F. Eichenfield, Jerry Bagel, Jamie W. Rhoads, and Amy S. Paller
Dysregulated autoantibodies targeting AGTR1 are associated with the accumulation of COVID-19 symptoms, Dennyson Leandro Fonseca, Maj Jäpel, Michael Adu Gyamfi, Igor Salerno Filgueiras, Gabriela Crispim Baiochi, Yuri Ostrinski, Gilad Halpert, Yael Bublil Lavi, Elroy Vojdani, Thayna Silva-Sousa, Júlia Nakanishi Usuda, Juan Carlo E Silva, Paula P. Freire, Adriel Leal Nóbile, Anny Silva Adri, Pedro Marçal Barcelos, Yohan Lucas Corrêa, Fernando Yuri do Vale, Letícia Oliveira Lopes, Solveig Lea Schmidt, Xiaoqing Wang, Carl Vahldieck, Benedikt Fels, Lena F. Schimke, Gustavo Cabral-Miranda, Mario Hiroyuki Hirata, Taj Ali AKhan, Yen-Rei A. Yu, Rodrigo Js Dalmolin, Howard Amital, Aristo Vojdani, and Haroldo Dutra Dias
Tapinarof cream 1% once daily was well tolerated in adults and children with atopic dermatitis in two phase 3 randomized trials, Linda Stein Gold, James Del Rosso, Benjamin D. Ehst, Matthew J. Zirwas, Lawrence J. Green, Philip M. Brown, David S. Rubenstein, Stephen C. Piscitelli, and Anna M. Tallman
Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body: The ARRECTOR Phase 3 Randomized Clinical Trial, Melinda J. Gooderham, Javier Alonso-Llamazares, Jerry Bagel, Neal Bhatia, Michael Bukhalo, Janet DuBois, Laura K. Ferris, Lawrence Green, Leon H. Kircik, Benjamin Lockshin, Wei Jing Loo, Kim A. Papp, Jennifer Soung, Melissa S. Seal, Scott Snyder, Saori Kato, David Krupa, Patrick Burnett, David R. Berk, and David H. Chu
Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic Hand Eczema: results of the phase 3 open-label extension DELTA 3 trial following the DELTA 1 and 2 trials, Melinda Gooderham, Sonja Molin, Robert Bissonnette, Margitta Worm, Marie-Noëlle Crépy, Luca Stingeni, Richard B. Warren, Sibylle Schliemann, Marie-Louise Schuttelaar, Silvia Ferrucci, Esther Serra-Baldrich, Jonathan I. Silverberg, Cherry Lou Balita-Crisostomo, Marie Louise Oesterdal, Ursula Plohberger, and Tove Agner
Boosting Skin Microcirculation for Androgenetic Alopecia: Does It Work?, Ayman Grada and Naiem Issa
Brodalumab as a Second-Line Therapy in Psoriasis: Rapid Response and Unique Mechanism of Action After Biologic Failure, Lawrence Green, April Armstrong, George Han, and Abby Jacobson
Two-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin), Emma Guttman-Yassky, Stephan Weidinger, Eric L. Simpson, Melinda Gooderham, Alan D. Irvine, Lynda Spelman, Jonathan I. Silverberg, Hany ElMaraghy, Louise DeLuca-Carter, Maria Lucia Piruzeli, Chaoran Hu, Fan Emily Yang, Evangeline Pierce, Laia Bardolet, and Diamant Thaçi
Burden of Pain and Use of Analgesics in Patients With Chronic Hand Eczema-Findings From the Danish Skin Cohort, Jeanette Halskou Haugaard, Johan Sieborg, Emma Guttman-Yassky, David Thein, Jonathan I. Silverberg, Lars Erik Kristensen, Jacob P. Thyssen, and Alexander Egeberg
The Heterogeneous Clinical Manifestations of Atopic Dermatitis Across Diverse Patient Populations, Joshua Horeczko, Andrew Alexis, and Jonathan I. Silverberg
The Heterogeneous Clinical Manifestations of Atopic Dermatitis Across Diverse Patient Populations, Joshua Horeczko, Andrew Alexis, and Jonathan I. Silverberg
North American Contact Dermatitis Group Patch Test Results: 2021-2022, Marie-Claude Houle, Joel G. DeKoven, Amber Reck Atwater, Margo J. Reeder, Erin M. Warshaw, Melanie D. Pratt, Donald V. Belsito, Brandon L. Adler, Jonathan Silverberg, JiaDe Yu, Nina Botto, Christen M. Mowad, Cory A. Dunnick, and James S. Taylor
Summary of Research: Comparable Efficacy and Safety of Brodalumab in Obese and Nonobese Patients with Psoriasis: Analysis of Two Randomized Controlled Trials, Sylvia Hsu, Lawrence J. Green, Mark G. Lebwohl, and Abby A. Jacobson
Summary of Research: Comparable Efficacy and Safety of Brodalumab in Obese and Nonobese Patients with Psoriasis: Analysis of Two Randomized Controlled Trials, Sylvia Hsu, Lawrence J. Green, Mark G. Lebwohl, and Abby A. Jacobson
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks, Alan D. Irvine, Vimal H. Prajapati, Emma Guttman-Yassky, Eric L. Simpson, Kim A. Papp, Andrew Blauvelt, Chia-Yu Chu, H Chih-Ho Hong, Linda F. Gold, Marjolein de Bruin-Weller, Thomas Bieber, Kenji Kabashima, David Rosmarin, Cristina Sancho, Brian M. Calimlim, Ayman Grada, Yang Yang, Xiaoqiang Wu, Gweneth Levy, Eliza M. Raymundo, Henrique D. Teixeira, and Jonathan I. Silverberg
Recommendations to Improve Outcomes in Acne and Acne Sequelae: A Focus on Trifarotene and Other Retinoids, Naiem Issa, Andrew Alexis, Hilary Baldwin, Iltefat Hamzavi, Adelaide Hebert, Pearl Kwong, Edward Lain, Angela Moore, Omar Noor, Todd Schlesinger, Jonathan Weiss, Heather Woolery-Lloyd, J P. York, Kate Zibilich Holcomb, Leon Kircik, and Rajeev Chavda
Recommendations to Improve Outcomes in Acne and Acne Sequelae: A Focus on Trifarotene and Other Retinoids, Naiem Issa, Andrew Alexis, Hilary Baldwin, Iltefat Hamzavi, Adelaide Hebert, Pearl Kwong, Edward Lain, Angela Moore, Omar Noor, Todd Schlesinger, Jonathan Weiss, Heather Woolery-Lloyd, J P. York, Kate Zibilich Holcomb, Leon Kircik, and Rajeev Chavda
Demystifying Small-Molecule Phosphodiesterase-IV Inhibition: Computer-Aided Rational Drug Design for Future Precision Drug Development, Naiem T. Issa
Real-World Use of Tapinarof Cream 1% Once Daily in Patients with Seborrheic Dermatitis: A Case Series, Naiem T. Issa and Lidia Pomaville
Acral Lentiginous Melanoma. Part II. Staging, Surgical Management, The Role of Systemic Therapy, Shortcomings and Future Directions, Daniella Jaguan, Sach Thakker, Micah Belzberg, Nina Gulati, Janeth R. Campbell, Brittney K. DeClerck, Vishal A. Patel, and Gino K. In
A Comparison of Large Language Model Powered Search Tools Reveal Differences in Output Quality, Information Transparency, and Accessibility for Mohs Micrographic Surgery Inquiries, Neil K. Jairath, Sumanth Chennareddy, Sophia Manduca, Adriana Lopez, Murad Alam, Nicholas Golda, Elise Ng, Vishal A. Patel, Emily S. Ruiz, Joshua W. Trufant, and Jesse M. Lewin
Factors Influencing Treatment Adherence in Chronic Spontaneous Urticaria: A Systematic Review, Aditya Joshi, Lauren Gawey, Muhammad Rahman, Raveena Ghanshani, Khiem A. Tran, Adam Friedman, Jennifer L. Hsiao, and Vivian Y. Shi
Consensus Statement on the Prevention and Management of Complications of Fully Ablative Laser Resurfacing of the Face, Bianca Y. Kang, Joel L. Cohen, Roy Geronemus, Suzanne L. Kilmer, Edward Victor Ross, Elizabeth L. Tanzi, Jill S. Waibel, Brian J. Wong, Murad Alam, Macrene Alexiades, Kenneth A. Arndt, Mathew Avram, Ashish C. Bhatia, Brian Stuart Biesman, Jason D. Bloom, A Jay Burns, Henry H. Chan, Catherine M. DiGiorgio, Jeffrey S. Dover, Sam Fathizadeh, Sara C. Esteves, Michael H. Gold, Gerald N. Goldberg, Merete Haedersdal, Elika Hoss, Omar A. Ibrahimi, H Ray Jalian, Kristen M. Kelly, Woraphong Manuskiatti, Lisa A. Marks, Girish S. Munavalli, and Jason N. Pozner
Real-world Evidence of Brodalumab Safety for the Treatment of Psoriasis, Mark Lebwohl, Eingun James Song, Tina Bhutani, Lawrence Green, and Abby Jacobson
The Association Between Atopic Dermatitis and Select Disease Events in Adults in the United States: A Retrospective Cohort Study in the Optum Electronic Health Records Database, Adina R. Lemeshow, Alexander Egeberg, Thomas Edwards, Stephen E. Schachterle, William Romero, Daniela E. Myers, Shefali Vyas, and Jonathan I. Silverberg
Successful treatment of recalcitrant amyopathic dermatomyositis with deucravacitinib in addition to intravenous immunoglobulin, Megan E. McNamara and Leonardo Tjahjono
Gene Expression Profiling (GEP) in Dermatology, Part 1: Introduction, Development, Benefits, Limitations, and Future Directions of GEP, Sino Mehrmal, Marcus G. Tan, Sarah T. Arron, John A. Carucci, Clay J. Cockerell, Aaron R. Mangold, Vishal A. Patel, Mark R. Pittelkow, Emily S. Ruiz, Ashley Wysong, and Stanislav N. Tolkachjov
What Does Long-Term Control in Atopic Dermatitis Look Like?, Shanthi Narla, Zelma C. Chiesa Fuxench, Katrina Abuabara, Lisa A. Beck, Raj Chovatiya, Diamant Thaçi, and Jonathan I. Silverberg
Current updates in the epidemiology and comorbidities of atopic dermatitis, Shanthi Narla and Jonathan I. Silverberg
Efficacy and Safety of Ruxolitinib Cream Combined With Narrow-Band UVB Phototherapy for Treatment of Vitiligo, Amit G. Pandya, Charles W. Lynde, Maryam Shayesteh Alam, Ira H. Thorla, Katherine Reed, Lawrence J. Green, Babak Soltanalizadeh, Diana Stefani-Hunyady, Deanna Kornacki, and Mark S. Amster
The Effectiveness of an Educational Intervention to Introduce Adolescents From Marginalized Backgrounds to Dermatology: A Pilot Initiative, Heli Patel, Hrushikesh Patel, Ross O'Hagan, Robert Smith, Adam Friedman, Rishab Revankar, Pamela Allen, and Seemal R. Desai
A Review of Glucagon-like Peptide-1 in Dermatology, Willmar Patino, Amanda Thomas, Sanjana Jain, James Q. Del Rosso, and Naiem T. Issa
A Scoping Review of Pruritic Papular Eruption in People Living With HIV, Vincent Pecora, Yagiz Matthew Akiska, and Adam Friedman
Treatment of Port Wine Birthmark With Nude Tattoo Using Multiple Laser Modalities, Vincent Pecora, Emily Murphy, and Pooja Sodha
Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma, Danny Rischin, Sandro Porceddu, Fiona Day, Daniel P. Brungs, Hayden Christie, James E. Jackson, Brian N. Stein, Yungpo Bernard Su, Rahul Ladwa, Gerard Adams, Samantha E. Bowyer, Zulfiquer Otty, Naoya Yamazaki, Paolo Bossi, Amarnath Challapalli, Axel Hauschild, Annette M. Lim, Vishal A. Patel, Joanna L. Walker, Maite De Liz Vassen Schurmann, Paola Queirolo, Javier Cañueto, Flavio Augusto Ferreira da Silva, Alexander Stratigos, Alexander Guminski, Charles Lin, Fernanda Damian, Lukas Flatz, Anne E. Taylor, David R. Carr, Samuel Harris, and Dmitry Kirtbaya
Consensus on core domains for hand eczema trials: Signs, symptoms, control and quality of life, Henriette Rönsch, Karl Philipp Drewitz, Amber Reck Atwater, Detlef Becker, Philipp Bentz, Richard Brans, Tricia Chong, Heinrich Dickel, Peter Elsner, Ana M. Giménez-Arnau, Fabrizio Guarneri, María Graciela Guzmán Perera, Sarah Ibrahim, Dimitra Koumaki, Jamie Koelbel, Francesca Larese Filon, Suzana Ljubojević Hadžavdić, Laura Loman, Mihaly Matura, Sonja Molin, Robert Ofenloch, Katharina Piontek, Radoslaw Spiewak, Anne Strunk, Margo Reeder, David Reissig, Thomas Rustemeyer, Marie-Louise Schuttelaar, Dagmar Simon, Manon Sloot, Markus F. Steiner, and Saïda Tongalaza
Choice of new treatment for patients with atopic dermatitis is associated with insurance status rather than race: A cross sectional study from commercial and Medicaid insurance claims databases, Maria C. Schneeweiss, Robert J. Glynn, Priyanka Anand, Yinzhu Jin, Joan Landon, and Jonathan I. Silverberg
Suicidal ideation in patients with atopic dermatitis: A case-control study on 23,191 adults, Julien Seneschal, Bruno Halioua, Jerry Tan, Chaoying Gu, Thomas Luger, Roni Dodiuk-Gad, Roberto Takaoka, Flavia Pretti Aslanian, Cita Rosita Prakoeswa, Ann' Laure Demessant-Flavigny, Caroline Le Floc'h, Nabil Kerrouche, Stéphanie Merhand, Wendy Smith Begolka, África Luca de Tena Smith, Shulamit Burstein, Delphine Kerob, Charles Taieb, Charbel Skayem, Abraham Getachew Kelbore, Laurent Misery, Therdpong Tempark, Alexander Stratigos, Martin Steinhoff, and Jonathan I. Silverberg
Ethical implications of ensuring follow-up care for free skin cancer screenings, Umayr R. Shaikh, Sarah H. Millan, Jeffrey M. Cohen, Jeffrey J. Miller, Adam J. Friedman, and Jane M. Grant-Kels